Filing Details

Accession Number:
0001493152-23-000225
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-01-04 08:30:25
Reporting Period:
2023-01-03
Accepted Time:
2023-01-04 08:30:25
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1835022 Coya Therapeutics Inc. COYA () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1637347 Adrian Hepner 5850 San Felipe St.,
Suite 500
Houston, TX 77057
Chief Medical Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, Par Value $0.0001 Per Share Acquisiton 2023-01-03 10,000 $0.00 10,000 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock, Par Value $0.0001 Per Share Warrant to Purchase Common Stock Acquisiton 2023-01-03 5,000 $0.00 5,000 $7.50
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
5,000 2023-01-03 2025-01-03 No 4 P Direct
Footnotes
  1. Reporting Person purchased 10,000 shares of Common Stock and an accompanying warrant to purchase 5,000 shares of Common Stock in the Issuer's initial public offering at a combined purchase price of $5.00 per share and accompanying warrant.